554 related articles for article (PubMed ID: 27314446)
21. Alveolar macrophages contribute to the pathogenesis of human metapneumovirus infection while protecting against respiratory syncytial virus infection.
Kolli D; Gupta MR; Sbrana E; Velayutham TS; Chao H; Casola A; Garofalo RP
Am J Respir Cell Mol Biol; 2014 Oct; 51(4):502-15. PubMed ID: 24749674
[TBL] [Abstract][Full Text] [Related]
22. Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model.
Mejías A; Chávez-Bueno S; Ríos AM; Saavedra-Lozano J; Fonseca Aten M; Hatfield J; Kapur P; Gómez AM; Jafri HS; Ramilo O
Antimicrob Agents Chemother; 2004 May; 48(5):1811-22. PubMed ID: 15105140
[TBL] [Abstract][Full Text] [Related]
23. H2S Attenuates LPS-Induced Acute Lung Injury by Reducing Oxidative/Nitrative Stress and Inflammation.
Zhang HX; Liu SJ; Tang XL; Duan GL; Ni X; Zhu XY; Liu YJ; Wang CN
Cell Physiol Biochem; 2016; 40(6):1603-1612. PubMed ID: 28006762
[TBL] [Abstract][Full Text] [Related]
24. Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model.
Olszewska W; Ispas G; Schnoeller C; Sawant D; Van de Casteele T; Nauwelaers D; Van Kerckhove B; Roymans D; De Meulder M; Rouan MC; Van Remoortere P; Bonfanti JF; Van Velsen F; Koul A; Vanstockem M; Andries K; Sowinski P; Wang B; Openshaw P; Verloes R
Eur Respir J; 2011 Aug; 38(2):401-8. PubMed ID: 21148224
[TBL] [Abstract][Full Text] [Related]
25. Respiratory syncytial virus induces airway insensitivity to beta-agonists in BALB/c mice.
Traylor ZP; Yu EN; Davis IC
Am J Physiol Lung Cell Mol Physiol; 2010 Mar; 298(3):L437-45. PubMed ID: 19965982
[TBL] [Abstract][Full Text] [Related]
26. BuShenYiQi Formula strengthens Th1 response and suppresses Th2-Th17 responses in RSV-induced asthma exacerbated mice.
Wang J; Wu J; Kong L; Nurahmat M; Chen M; Luo Q; Li B; Wu X; Dong J
J Ethnopharmacol; 2014 May; 154(1):131-47. PubMed ID: 24704667
[TBL] [Abstract][Full Text] [Related]
27. Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infection.
Empey KM; Orend JG; Peebles RS; Egaña L; Norris KA; Oury TD; Kolls JK
PLoS One; 2012; 7(7):e40499. PubMed ID: 22792355
[TBL] [Abstract][Full Text] [Related]
28. Effect of glucocorticoid in mice of asthma induced by ovalbumin sensitisation and RSV infection.
Chi XY; Jiang SJ; Wang J; Wang JP
Asian Pac J Allergy Immunol; 2011 Jun; 29(2):176-80. PubMed ID: 21980833
[TBL] [Abstract][Full Text] [Related]
29. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
Ohol YM; Wang Z; Kemble G; Duke G
PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560
[TBL] [Abstract][Full Text] [Related]
30. Effects of intranasal treatment with slow (GYY4137) and rapid (NaHS) donors of hydrogen sulfide in lipopolysaccharide-induced airway inflammation in mice.
Kaya-Yasar Y; Karaman Y; Bozkurt TE; Onder SC; Sahin-Erdemli I
Pulm Pharmacol Ther; 2017 Aug; 45():170-180. PubMed ID: 28645584
[TBL] [Abstract][Full Text] [Related]
31. Histone deacetylase inhibitors suppress RSV infection and alleviate virus-induced airway inflammation.
Feng Q; Su Z; Song S; Χu H; Zhang B; Yi L; Tian M; Wang H
Int J Mol Med; 2016 Sep; 38(3):812-22. PubMed ID: 27460781
[TBL] [Abstract][Full Text] [Related]
32. Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis.
Xu S; Liu Z; Liu P
Int J Cardiol; 2014 Mar; 172(2):313-7. PubMed ID: 24491853
[TBL] [Abstract][Full Text] [Related]
33. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
Fuentes S; Arenas D; Moore MM; Golding H; Khurana S
Vaccine; 2017 Jan; 35(4):694-702. PubMed ID: 27989627
[TBL] [Abstract][Full Text] [Related]
34. H
Magli E; Perissutti E; Santagada V; Caliendo G; Corvino A; Esposito G; Esposito G; Fiorino F; Migliaccio M; Scognamiglio A; Severino B; Sparaco R; Frecentese F
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944543
[TBL] [Abstract][Full Text] [Related]
35. Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model.
Chávez-Bueno S; Mejías A; Gómez AM; Olsen KD; Ríos AM; Fonseca-Aten M; Ramilo O; Jafri HS
Virol J; 2005 May; 2():46. PubMed ID: 15916706
[TBL] [Abstract][Full Text] [Related]
36. Antiviral effects of modified dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model.
Li L; Yu CH; Ying HZ; Yu JM
J Ethnopharmacol; 2013 May; 147(1):238-44. PubMed ID: 23506991
[TBL] [Abstract][Full Text] [Related]
37. MMP-12-mediated by SARM-TRIF signaling pathway contributes to IFN-γ-independent airway inflammation and AHR post RSV infection in nude mice.
Long X; Li S; Xie J; Li W; Zang N; Ren L; Deng Y; Xie X; Wang L; Fu Z; Liu E
Respir Res; 2015 Feb; 16(1):11. PubMed ID: 25652021
[TBL] [Abstract][Full Text] [Related]
38. DSCG reduces RSV-induced illness in RSV-infected mice.
Hashimoto K; Mori S; Hashimoto Y; Kaneko H; Ishibashi K; Ishioka K; Kawasaki Y; Peebles RS; Munakata M; Hosoya M; Suzutani T
J Med Virol; 2009 Feb; 81(2):354-61. PubMed ID: 19107959
[TBL] [Abstract][Full Text] [Related]
39. Exogenous hydrogen sulfide (H2S) protects alveolar growth in experimental O2-induced neonatal lung injury.
Vadivel A; Alphonse RS; Ionescu L; Machado DS; O'Reilly M; Eaton F; Haromy A; Michelakis ED; Thébaud B
PLoS One; 2014; 9(3):e90965. PubMed ID: 24603989
[TBL] [Abstract][Full Text] [Related]
40. Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease.
Su YC; Townsend D; Herrero LJ; Zaid A; Rolph MS; Gahan ME; Nelson MA; Rudd PA; Matthaei KI; Foster PS; Dent L; Tripp RA; Lee J; Simson L; Mahalingam S
J Virol; 2015 Feb; 89(3):1564-78. PubMed ID: 25410867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
